Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review
International Journal of Drug Policy(2023)
Abstract
•COVID-19 pandemic led to amendments to regulations for opioid medications.•Most providers supported flexibilities around take-homes, despite initial caution.•Providers developed new processes to make decisions around take-homes.•Flexibility around take-homes favoured person-centred care approaches.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined